---
figid: PMC8910147__ijms-23-02642-g001
figtitle: 'CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic
  Perspectives'
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Cricetus cricetus
- Homo sapiens
- unidentified
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Danio rerio
pmcid: PMC8910147
filename: ijms-23-02642-g001.jpg
figlink: /pmc/articles/PMC8910147/figure/ijms-23-02642-f001/
number: F1
caption: CXCL/CXCR interactions in the tumor microenvironment (TME). Ovarian cancer
  cells are surrounded by a variety of different types of cells in the TME, and these
  cells communicate primarily via chemokines to regulate cancer cell proliferation,
  migration, and angiogenesis. Specifically, CAF-produced CXCL12 acts on CXCR4/7 and
  leads to activation of the MAPK pathway in cancer cells and the maturation of M2
  macrophages which secrete ARG-1 to inhibit anti-tumor immunity. HIF-1α and HIF-2α
  induce M2 macrophages to express CXCL8/16 in the hypoxic environment; CXCL8/16 activates
  WNT/β-Catenin, PI3K/AKT, NF-KB, and VEGF signaling pathways in cancer cells and
  promotes cancer progression. CAF-produced CXCL11 promotes cancer cell proliferation
  and migration. Cancer cell-secreted CXCL12 recruits pDCs which produce angiogenic
  factors CXCL8 and TNF-α. Cancer cell-secreted CXCL1/5 recruits Neus, and IL-17A
  produced by Neus stimulates cancer cells to secrete more CXCL1. Cancer cell-secreted
  PAI-1 activates the NF-κB pathway and upregulates CXCL5/8 expression in CAMs. CSC-secreted
  MIF acts on CXCR2 and upregulates ARG-1 in MDSCs. ARG-1, arginase-1; PAI-1, plasminogen
  activator inhibitor-1; MIF, macrophage migration inhibitory factor. (Created with
  BioRender.com).
papertitle: 'CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer:
  Theranostic Perspectives.'
reftext: Xinxin Huang, et al. Int J Mol Sci. 2022 Mar;23(5):2642.
year: '2022'
doi: 10.3390/ijms23052642
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: ovarian cancer | CXC chemokine ligand (CXCL) | CXC chemokine receptor (CXCR)
  | tumor microenvironment (TME)
automl_pathway: 0.8950772
figid_alias: PMC8910147__F1
figtype: Figure
redirect_from: /figures/PMC8910147__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8910147__ijms-23-02642-g001.html
  '@type': Dataset
  description: CXCL/CXCR interactions in the tumor microenvironment (TME). Ovarian
    cancer cells are surrounded by a variety of different types of cells in the TME,
    and these cells communicate primarily via chemokines to regulate cancer cell proliferation,
    migration, and angiogenesis. Specifically, CAF-produced CXCL12 acts on CXCR4/7
    and leads to activation of the MAPK pathway in cancer cells and the maturation
    of M2 macrophages which secrete ARG-1 to inhibit anti-tumor immunity. HIF-1α and
    HIF-2α induce M2 macrophages to express CXCL8/16 in the hypoxic environment; CXCL8/16
    activates WNT/β-Catenin, PI3K/AKT, NF-KB, and VEGF signaling pathways in cancer
    cells and promotes cancer progression. CAF-produced CXCL11 promotes cancer cell
    proliferation and migration. Cancer cell-secreted CXCL12 recruits pDCs which produce
    angiogenic factors CXCL8 and TNF-α. Cancer cell-secreted CXCL1/5 recruits Neus,
    and IL-17A produced by Neus stimulates cancer cells to secrete more CXCL1. Cancer
    cell-secreted PAI-1 activates the NF-κB pathway and upregulates CXCL5/8 expression
    in CAMs. CSC-secreted MIF acts on CXCR2 and upregulates ARG-1 in MDSCs. ARG-1,
    arginase-1; PAI-1, plasminogen activator inhibitor-1; MIF, macrophage migration
    inhibitory factor. (Created with BioRender.com).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCR4
  - CXCL1
  - CXCL9
  - CXCL10
  - ARG1
  - TINAGL1
  - CXCL8
  - CXCL16
  - KAT2B
  - CXCL12
  - CD8A
  - CD8B
  - CXCR6
  - CXCR3
  - CXCR2
  - CXCR1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CXCL11
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - CD4
  - ACKR3
  - CXCR5
  - CXCL5
  - PDC
  - PNKD
  - IL17A
  - MIF
  - AMH
  - S100A8
  - S100A9
  - SERPINE1
  - ERBB2
  - NEU1
  - NEURL1
  - TNFRSF10B
  - Ugt2b5
  - Cxcr4
  - Cxcl1
  - Cxcl9
  - Cxcl10
  - Arg1
  - Cxcl16
  - Caf
  - Cxcl12
  - Cxcr6
  - Cxcr3
  - Cxcr2
  - Cxcr1
  - Ctnnb1
  - Akt1
  - Pik3r1
  - Nfkb1
  - Vegfa
  - Cxcl11
  - Calm1
  - Tmem50a
  - Fos
  - Cd4
  - Ackr3
  - Cxcr5
  - Cxcl5
  - Pdc
  - Il17a
  - Mif
  - Serpine1
  - Serpine2
  - Erbb2
  - Neu1
  - Tnfrsf10b
  - Wnt2
  - Pik3cg
  - Calm2
  - Cxcl6
  - cxcr4b
  - arg1
  - cxcl8a
  - cxcl12a
  - cxcr2
  - ctnnb1
  - vegfaa
  - cxcl11.7
  - fosab
  - ighv1-1
  - cd4-1
  - cxcr7
  - cxcr5
  - pdca
  - mif
  - serpine1
---
